Dr. Vijayashree Murthy

• Dr. Vijayashree Murthy is a renowned medical professional specializing in breast oncology.
• With years of experience, she has established herself as a leading expert in the field of breast cancer treatment.
• Dr. Murthy’s dedication to patient care and her contributions to breast oncology research have earned her a distinguished reputation.
• Dr. Vijayashree Murthy has been actively involved in both clinical practice and research, working to advance the understanding and treatment of breast cancer.
• Dr. Murthy’s comprehensive approach to breast oncology involves early detection, accurate diagnosis, personalized treatment plans, and compassionate patient support.

Her expertise covers a wide range of breast cancer types, stages, and treatment modalities, including surgery, chemotherapy, radiation therapy, targeted therapies, and immunotherapy.

Dr. Vijayashree Murthy has been a strong advocate for patient education, empowering individuals with knowledge about breast health, risk factors, and available treatment options.

Dr. Vijayashree Murthy has been a speaker at various medical conferences and seminars, sharing her insights on the latest developments in breast oncology.

Dr. Murthy’s research contributions have led to advancements in treatment protocols and improved outcomes for breast cancer patients.

Experience of Dr. Vijayashree Murthy

Dr. Vijayashree Murthy has 20  years of total experience in this field.

• MS (General Surgery) from Lokmanya Tilak Municipal College and Hospital
• MCh (Surgical Oncology) training at Kidwai Memorial Institute of Oncology

• Oncoplastic breast surgery
• Breast Conservation surgery
• Lumpectomy
• Sentinel lymph node biopsy
• Axillary surgery with minimum morbidity
• Axillary lymph node dissection

• English
• Hindi

• Okano I, Rosenberg+I3:I25 A, Dworkin M, Murthy V, Jayaraman S, Takabe K. Direct and indirect health effects of the nuclear power plant disasters: a review for health care professionals. Int J Surg:Global Health. 2022 Sep; 5(5): pe71.
• Tokumaru Y, Oshi M, Murthy V, Tian W, Yan L, Angarita FA, Nagahashi M, Matsuhashi N, Futamura M, Yoshida K, Miyoshi Y, Takabe K. Low intratumoral genetic neutrophil-to-lymphocyte ratio (NLR) is associated with favorable tumor immune microenvironment and with survival in triple negative breast cancer (TNBC). Am J Cancer Res. 2021 Nov 15;11(11):5743-5755.
• Gandhi S, Oshi M, Murthy V, Repasky EA, Takabe K. Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment. Cancers (Basel) 2021 May 23;13(11):2559.
• Murthy V, Young J, Tokumaru Y, Quinn M, Edge SB, Takabe K. Options to Determine Pathological Response of Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Advanced Breast Cancer. Cancers (Basel). 2021 Aug 19;13(16):4167.
• Murthy V, Oshi M, Tokumaru Y, Endo I, Takabe K. Increased apoptosis is associated with robust immune cell infiltration and cytolytic activity in breast cancer. Am J Cancer Res. 2021 Jul 15;11(7):3674-3687.
• Oshi M, Murthy V, Takahashi H, Huyser M, Okano M, Tokumaru Y, Rashid OM, Matsuyama R, Endo I, Takabe K. Urine as a Source of Liquid Biopsy for Cancer. Cancers (Basel). 2021 May 28;13(11):2652.